Company Filing History:
2 out of 818 
2 out of 757 
2 out of 61 
Years Active: 2019
Title: Michael Pollastri: Innovator in Cancer Therapeutics
Introduction
Michael Pollastri is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of cancer therapeutics, holding 2 patents that focus on innovative approaches to inhibit cancer cell proliferation and metastasis.
Latest Patents
Pollastri's latest patents include the development of Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics. These patents provide novel agents that modulate AhR activity for use in therapeutic compositions and methods aimed at inhibiting cancer cell proliferation and tumor cell invasion and metastasis. The agents comprise AhR inhibitors or non-constitutive AhR agonists of specific formulas for the inhibition of cancer cell growth and parameters that characterize tumor metastasis, such as tumor cell invasiveness.
Career Highlights
Throughout his career, Pollastri has worked with prestigious institutions, including Boston University and Northeastern University. His research has focused on the modulation of AhR activity, contributing to advancements in cancer treatment.
Collaborations
Pollastri has collaborated with notable colleagues, including David H. Sherr and Jennifer Schlezinger, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Michael Pollastri's innovative work in cancer therapeutics exemplifies the potential of scientific research to address critical health challenges. His contributions continue to pave the way for new treatment options in oncology.